Twist Bioscience Corporation Common Stock
Here’s whether Twist Bioscience Corporation Common Stock (TWST) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+9.22% over 10 days); strong 1-year return of +126.5%; 3-month momentum positive (+69.2%). Concerns: RSI 72 — overbought, elevated pullback risk. Currently 5.4% off its 52-week high. Score: +5/7.
TWST is in a confirmed uptrend, trading above both its 50-day ($59.79) and 200-day ($42.04) moving averages. With an RSI of 72.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +126.5% compares to +22.9% for SPY (beat the market by 103.6%).